Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 23,899 - -
Change - -49.85% 49.53% -8.95% -16.56% 20.74% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 23,396 22,860 22,440
Change - -51.82% 51.78% -7.74% -18.07% 21.81% -2.29% -1.83%
P/E 54.1x 30.4x 44.7x 49x 40.5x 39.6x 34.4x 30.8x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 7.63x 6.66x 5.89x
PEG - -2.8x 23.04x -3.2x 27.09x 1.5x 2.3x 2.6x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.09x 6.67x 6.21x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 6.94x 6.38x 5.83x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 24.8x 21.9x 19.3x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 31x 27x 23.7x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 51.4x 41.2x 31x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.94% 2.43% 3.23%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.9028 0.9733 1.12
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.27% 0.29% 0.33%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.575 9.865 11.04
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.5% 9.87% 10.1%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,371 3,583 3,846
EBITDA 1 884.7 882.6 827.9 728.2 793.8 941.8 1,042 1,160
EBIT 1 762.4 762 690.6 572.8 622.4 755.9 846 948
Net income 1 661.8 585.9 593.4 492.7 493.7 614.5 701.2 778
Net Debt 1 - -685.4 -647.1 -282 -588.5 -503.3 -1,039 -1,458
Reference price 2 469.01 235.35 352.12 327.56 275.14 339.59 339.59 339.59
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,376 - -
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
39.6x6.94x24.84x0.27% 23.9B
30.24x4.11x15.98x2.44% 183B
19.42x3.39x11.94x3.47% 110B
17.37x0.19x12.26x0.76% 60.75B
30.04x7.29x19x1.33% 50.01B
36.03x3.22x10.97x2.37% 45.59B
37.5x1.37x12.06x0.21% 33.08B
30.28x5.41x17.22x-.--% 28.76B
24.62x3.73x13.08x1.13% 22.53B
21.18x2.93x11.3x1.49% 22.35B
Average 28.63x 3.86x 14.86x 1.35% 57.94B
Weighted average by Cap. 27.51x 3.73x 14.60x 1.93%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Valuation West Pharmaceutical Services, Inc.